NCT02659124

Brief Summary

This is a comparison trial with novel application of AmnioFix and a control arm. Patients electively being treated with facial lasers will be assigned to receive AmnioFix in addition to the normal standard of care placed on half of their face after laser procedure, and normal post laser standard of care alone on the other half of their face. The investigators will investigate the end points of healing, recovery time, re-epitheliaziation, and other cosmetic factors. The study is designed to compare AmnioFix to the current standard of laser care.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 20, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

March 21, 2022

Status Verified

March 1, 2022

First QC Date

January 11, 2016

Last Update Submit

March 7, 2022

Conditions

Keywords

facial laserfraction ablative resurfacingtotal ablative resurfacingEpiFixrhytideswrinklesAmnioFix

Outcome Measures

Primary Outcomes (1)

  • Time of reepithelialization

    Subjects' healing and recovery is the primary outcome measure. Reepithelialization will be assessed at each follow up visit, considering the following: erythema, edema/induration, and oozing/drainage.

    28 days after treatment

Study Arms (1)

Standard of Care plus AmnioFix

OTHER

All patients will receive the standard of care alone on half of their face, and AmnioFix in addition to the standard of care on the other half of their face.

Device: AmnioFix plus Standard of CareProcedure: Standard of Care

Interventions

Patients will receive the standard of care alone on half of their face, and AmnioFix in addition to the standard of care on the other half of their face. The standard of care after ablative resurfacing is conservative wound care which may include flexible wound care dressings and/or emollients.

Standard of Care plus AmnioFix

Patients will receive the standard of care dressing only, on their face. The standard of care after ablative resurfacing is conservative wound care which may include flexible wound care dressings and/or emollients.

Standard of Care plus AmnioFix

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients ages 18-100 seeking laser facial treatment

You may not qualify if:

  • patients with treatment areas with active or latent infection
  • patient with a disorder that would create an unacceptable risk of post-operative complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF Dermatology

San Francisco, California, 94115, United States

Location

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2016

First Posted

January 20, 2016

Primary Completion

April 1, 2017

Study Completion

January 1, 2018

Last Updated

March 21, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations